DOSSIER · 13F Holders · Q2 2026
IPHA
INNATE PHARMA SA-SPONS ADR
10 institutions still hold INNATE PHARMA SA-SPONS ADR as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 45781K204·10 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
10 institutions reported IPHA in Q2 2026. Lion Point Capital, LP leads at 40.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.